clinical trial · NCT02792842
Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer
Postoperative Stage II/III Colon CancerART-123 (3-day ART)ART-123 (1-day ART)Placebo
brief summary
The purpose of this study is to evaluate the efficacy and safety of ART-123 for the prevention of cancer treatment related symptoms in patients with postoperative stage II / III colon cancer.
started
Jul 1, 2016
primary completion
Feb 1, 2018
completion
Feb 1, 2018
last updated
Apr 4, 2024
official title
Phase 2 Clinical Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer: a Multicenter Randomized Placebo-controlled Double-blind Study to Investigate the Efficacy and Safety of ART-123
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol